Patents by Inventor Akio Nomoto

Akio Nomoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer cell growth inhibitor, anticancer agent, and method for screening same, as well as novel compound
    Patent number: 9969699
    Abstract: A cancer cell proliferation inhibitor including at least one selected from compounds represented by Structural Formulae (1) to (8), wherein the cancer cell is at least one of a cancer cell overexpressing a wild-type epidermal growth factor receptor and a cancer cell expressing an epidermal growth factor receptor mutant vIII.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: May 15, 2018
    Assignees: Microbial Chemistry Research Foundation, GAKUBUNKAN
    Inventors: Sonoko Atsumi, Masabumi Shibuya, Shun-ichi Ohba, Tomoyuki Kimura, Yoshihiko Kobayashi, Hayamitsu Adachi, Chisato Nosaka, Akio Nomoto
  • Cancer Cell Growth Inhibitor, Anticancer Agent, and Method for Screening Same, as well as Novel Compound
    Publication number: 20170291879
    Abstract: A cancer cell proliferation inhibitor including at least one selected from compounds represented by Structural Formulae (1) to (8), wherein the cancer cell is at least one of a cancer cell overexpressing a wild-type epidermal growth factor receptor and a cancer cell expressing an epidermal growth factor receptor mutant vIII.
    Type: Application
    Filed: September 7, 2015
    Publication date: October 12, 2017
    Inventors: Sonoko Atsumi, Masabumi Shibuya, Shun-ichi Ohba, Tomoyuki Kimura, Yoshihiko Kobayashi, Hayamitsu Adachi, Chisato Nosaka, Akio Nomoto
  • Method for Detecting SMN Protein Expression
    Publication number: 20170115297
    Abstract: Provided is a method for detecting the expression of SMN protein, said method comprises: a step for labeling SMN protein in a sample, said sample containing nucleated cells derived from blood; a step for labeling the nuclei of the nucleated cells in the sample; a step for selecting a cell population of the nucleated cells in which nuclei and SMN protein are labeled; and a step for detecting the expression of the SMN protein on the basis of the label for the SMN protein in the selected cell population.
    Type: Application
    Filed: April 3, 2015
    Publication date: April 27, 2017
    Applicant: Tokyo Women's Medical University
    Inventors: Kayoko SAITO, Reiko ARAKAWA, Masayuki ARAKAWA, Akio NOMOTO (Deceased)
  • Drug transporter permeating blood-brain barrier, peptide and use thereof
    Patent number: 9156889
    Abstract: A peptide, wherein the peptide comprises an amino acid sequence expressed by the following SEQ ID NO: 1, an amino acid sequence expressed by the following SEQ ID NO: 2, an amino acid sequence expressed by the following SEQ ID NO: 3, an amino acid sequence expressed by the following SEQ ID NO: 4, or any combination thereof: (SEQ?ID?NO:?1) ALGDSLYGAASLN; (SEQ?ID?NO:?2) MTVDNPASTTNKDKLFSVWK; (SEQ?ID?NO;?3) PGAVPEK; and (SEQ?ID?NO:?4) STKDLTTY.
    Type: Grant
    Filed: July 31, 2013
    Date of Patent: October 13, 2015
    Assignee: Microbial Chemistry Research Foundation
    Inventors: Akio Nomoto, Coh-ichi Nihei
  • Drug Transporter Permeating Blood-Brain Barrier, Peptide and Use Thereof
    Publication number: 20130337050
    Abstract: A peptide, wherein the peptide comprises an amino acid sequence expressed by the following SEQ ID NO: 1, an amino acid sequence expressed by the following SEQ ID NO: 2, an amino acid sequence expressed by the following SEQ ID NO: 3, an amino acid sequence expressed by the following SEQ ID NO: 4, or any combination thereof: (SEQ?ID?NO:?1) ALGDSLYGAASLN; (SEQ?ID?NO:?2) MTVDNPASTTNKDKLFSVWK; (SEQ?ID?NO;?3) PGAVPEK; and (SEQ?ID?NO:?4) STKDLTTY.
    Type: Application
    Filed: July 31, 2013
    Publication date: December 19, 2013
    Applicants: ImmunoFuture, Inc., Microbial Chemistry Research Foundation
    Inventors: Akio NOMOTO, Coh-ichi NIHEI
  • Method for examining neurovirulence of polio virus
    Patent number: 5986171
    Abstract: The present invention relates to a method of examining the neurovirulence of a polio virus, which comprises inoculating a polio virus into the spinal cord of a transgenic mouse comprising a gene for a polio virus receptor.
    Type: Grant
    Filed: November 15, 1995
    Date of Patent: November 16, 1999
    Assignees: Japan Poliomyelitis Research Institute, Central Institute for Experimental Animals
    Inventors: Shinobu Abe, Yoshihiro Ota, So Hashizume, Satoshi Koike, Akio Nomoto, Hiromichi Yonekawa, Choji Taya, Tatsuji Nomura